[Does the basic therapy affect the development of secondary amyloidosis in rheumatoid arthritis?]. / Vliiaet li terapiia bazisnogo riada na razvitie vtorichnogo amiloidoza pri revmatoidnom artrite?
Ter Arkh
; 67(5): 47-9, 1995.
Article
en Ru
| MEDLINE
| ID: mdl-7638779
ABSTRACT
Anti-rheumatic drug treatments were studied in 260 patients from Finland and Russia suffering from rheumatoid arthritis (RA) with or without biopsy-proven secondary amyloidosis (RSA). Chloroquine was used for longer period in RSA group in Russia (p = 0.003) and in Finland (p = 0.06). In Finland chloroquine was used more often in the RSA group (p = 0.02), and sulphasalazine (p = 0.02), D-penicillamine (p = 0.03) and cytotoxics (p = 0.04) in the control group. The role of therapy in the prevention of RSA in chronic inflammation is discussed.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Amiloidosis
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Asia
/
Europa
Idioma:
Ru
Revista:
Ter Arkh
Año:
1995
Tipo del documento:
Article